Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 430
Filter
1.
Diagn Microbiol Infect Dis ; 110(3): 116484, 2024 Nov.
Article in English | MEDLINE | ID: mdl-39146635

ABSTRACT

Ehrlichiosis and anaplasmosis are rising tickborne infections posing significant risks to solid-organ transplant (SOT) patients. We present three cases highlighting clinical presentations, diagnostic challenges, and the benefits of microbial cell-free DNA (mcfDNA) sequencing. Emphasizing early diagnosis and preventive measures, we advocate for advanced diagnostic modalities to improve outcomes in this vulnerable population.


Subject(s)
Anaplasmosis , Ehrlichiosis , Organ Transplantation , Humans , Anaplasmosis/diagnosis , Anaplasmosis/microbiology , Ehrlichiosis/diagnosis , Ehrlichiosis/drug therapy , Ehrlichiosis/microbiology , Male , Middle Aged , Female , Organ Transplantation/adverse effects , Adult , Aged , DNA, Bacterial/genetics , Transplant Recipients
2.
Microbiol Spectr ; 12(8): e0065524, 2024 Aug 06.
Article in English | MEDLINE | ID: mdl-38980020

ABSTRACT

Emerging tick-borne illnesses, such as anaplasmosis, babesiosis, or ehrlichiosis, are caused by obligate intracellular pathogens that have clinically comparable presentations. Diagnostics used in laboratories today are serologic assays and blood smear analyses, which have known diagnostic limits. This study evaluated the performance of a sample-to-answer direct real-time PCR laboratory-developed test for the multiplex qualitative detection of Anaplasma, Babesia, and Ehrlichia DNA in whole-blood specimens. Compared to two standard-of-care (SOC) methods, the DiaSorin tick-borne laboratory-developed test for Anaplasma detection demonstrated a positive percent agreement (PPA) and negative percent agreement (NPA) of 100% (95% CI, 0.80 to 1.0) and 89% (95% CI, 0.74 to 0.97), respectively with a discordant rate of 9.3% against microscopy. After discordant resolution, the NPA increased to 100%. For Babesia, the test demonstrated a PPA of 100% (95% CI, 0.90 to 1.0) and NPA of 100% (95% CI, 0.90 to 1.0). Compared to a SOC PCR method Anaplasma samples showed a PPA of 100% (95% CI, 0.66 to 1.0) and NPA of 100% (95% CI, 0.90 to 1.0). Ehrlichia results showed a PPA of 100% (95% CI, 0.69 to 1.0) and NPA of 100% (95% CI, 0.90 to 1.0). The total percent agreement was 98% (95% CI, 0.95 to 0.99) with a κ statistic of 0.95 (95% CI, 0.90 to 0.99) or almost perfect agreement compared to SOC methods. This laboratory-developed test for detecting Anaplasma, Babesia, and Ehrlichia DNA provides rapid and reliable detection of tick-borne infections without nucleic acid extraction. IMPORTANCE: This work demonstrates that detection of tick-borne illnesses, such as anaplasmosis, babesiosis, or ehrlichiosis, can be performed directly from whole blood with no extraction. The assay described here has a high positive and negative percent agreement with existing methods and is used as the standard of care. An increasing incidence of tick-borne illness combined with shortage of well-trained technologists to perform traditional manual testing, testing options that can be adapted to various lab settings, are of the utmost importance.


Subject(s)
Anaplasma phagocytophilum , Anaplasmosis , Babesia , Babesiosis , Ehrlichia , Ehrlichiosis , Real-Time Polymerase Chain Reaction , Humans , Ehrlichia/isolation & purification , Ehrlichia/genetics , Anaplasma phagocytophilum/isolation & purification , Anaplasma phagocytophilum/genetics , Real-Time Polymerase Chain Reaction/methods , Ehrlichiosis/diagnosis , Ehrlichiosis/microbiology , Babesiosis/diagnosis , Babesiosis/parasitology , Babesiosis/blood , Babesia/isolation & purification , Babesia/genetics , Anaplasmosis/diagnosis , Anaplasmosis/microbiology , Sensitivity and Specificity , Tick-Borne Diseases/diagnosis , Tick-Borne Diseases/microbiology , Tick-Borne Diseases/parasitology , DNA, Bacterial/genetics , DNA, Bacterial/blood
3.
Am J Case Rep ; 25: e943966, 2024 Jul 15.
Article in English | MEDLINE | ID: mdl-39004878

ABSTRACT

BACKGROUND Anaplasmosis, or human granulocytic anaplasmosis (HGA), is a tick-borne diseased caused by a gram-negative, intracellular bacterium, Anaplasma phagocytophilum. HGA usually presents with mild symptoms but can be more severe. This report describes a 67-year-old male resident of rural Pennsylvania, admitted to the hospital after a fall, who developed fatal acute respiratory distress syndrome (ARDS) associated with human granulocytic anaplasmosis (HGA) following transmission of Anaplasma phagocytophilum by a tick bite (Ixodes scapularis). CASE REPORT A 67-year-old man, resident of rural Pennsylvania, with history of diabetes mellitus, presented after falling from a 7-foot-tall ladder, sustaining right-sided hemopneumothorax, multiple right rib fractures, and unstable T12 vertebra fracture. He required tube thoracostomy and underwent T9-L2 posterior spinal fusion surgery. His initial labs showed leukopenia, thrombocytopenia, and elevated transaminase levels. His course was complicated by cardiac arrest and acute respiratory failure, consistent with severe ARDS. He received high positive end-expiratory pressure (PEEP) ventilation, prone positioning, and neuromuscular paralysis to improve refractory hypoxemia. Bronchoalveolar lavage (BAL) for bacterial, fungal, viral pathogens, Covid-19, respiratory viral panel, Mycoplasma pneumoniae, and Chlamydia pneumoniae were negative. his family withdrew medical care, knowing the patient's own wishes, and the patient died. Polymerase chain reaction (PCR) for Anaplasma DNA came back positive after the patient's death. His peripheral smear was then examined, showing morulae inside the cytoplasm of infected neutrophils.   CONCLUSIONS This report describes the atypical presentation of a case of HGA and highlights that in parts of the world where tick-borne diseases are endemic, disease awareness, high index of clinical suspicion, and early diagnosis and management are required.


Subject(s)
Anaplasma phagocytophilum , Respiratory Distress Syndrome , Humans , Male , Aged , Respiratory Distress Syndrome/etiology , Fatal Outcome , Anaplasma phagocytophilum/isolation & purification , Anaplasmosis/diagnosis , Anaplasmosis/complications , Tick Bites/complications
4.
Sci Rep ; 14(1): 16888, 2024 07 23.
Article in English | MEDLINE | ID: mdl-39043715

ABSTRACT

Tick-borne diseases in animals are increasing rapidly worldwide, but there is insufficient information about tick-borne diseases infecting dogs in southern Egypt. Thus, in the current study, we detected the presence of Anaplasma marginale (A. marginale) and Babesia canis vogeli (B. canis vogeli) in the blood of dogs. The results revealed that 4/100 (4%) were positive, and a higher infection rate was found in males (75%), than females (25%). The phylogenetic analysis for the major surface protein 4 (msp4) gene in this study was compared with amplicons separate from other reported isolates with alignment by identity 100% with cattle and camels from Egypt, and the phylogenetic analysis for the B. canis vogeli small subunit ribosomal RNA (SSU rRNA) gene in this study identified identity by 99.89% with dogs from Egypt. This report is considered the first report in southern Egypt about A. marginale in dogs based on the sequence analysis of the msp4 gene, providing new data for the classification and identification of A. marginale in dogs compared to A. marginale isolated from other animals in southern Egypt.


Subject(s)
Anaplasma marginale , Anaplasmosis , Babesia , Babesiosis , Dog Diseases , Phylogeny , Animals , Dogs , Egypt/epidemiology , Babesia/genetics , Babesia/isolation & purification , Babesia/classification , Anaplasmosis/microbiology , Anaplasmosis/epidemiology , Anaplasmosis/diagnosis , Anaplasma marginale/genetics , Anaplasma marginale/isolation & purification , Dog Diseases/parasitology , Dog Diseases/microbiology , Dog Diseases/diagnosis , Babesiosis/parasitology , Babesiosis/epidemiology , Babesiosis/diagnosis , Female , Male
5.
Emerg Med Clin North Am ; 42(3): 597-611, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38925777

ABSTRACT

This review highlights the causative organisms, clinical features, diagnosis, and treatment of the most common tick-borne illnesses in the United States, including Lyme disease, Rocky Mountain spotted fever, anaplasmosis, ehrlichiosis, tularemia, Powassan virus, and alpha-gal syndrome. Tick bite prevention strategies and some basic tick removal recommendations are also provided.


Subject(s)
Tick-Borne Diseases , Humans , Tick-Borne Diseases/diagnosis , Tick-Borne Diseases/therapy , Tick-Borne Diseases/epidemiology , Animals , Wilderness Medicine , Lyme Disease/diagnosis , Lyme Disease/therapy , Lyme Disease/epidemiology , Rocky Mountain Spotted Fever/diagnosis , Rocky Mountain Spotted Fever/therapy , Rocky Mountain Spotted Fever/epidemiology , United States/epidemiology , Ticks/virology , Tick Bites/therapy , Ehrlichiosis/diagnosis , Ehrlichiosis/epidemiology , Ehrlichiosis/therapy , Ehrlichiosis/drug therapy , Anaplasmosis/diagnosis , Anaplasmosis/epidemiology , Anaplasmosis/therapy
6.
WMJ ; 123(2): 141-143, 2024 May.
Article in English | MEDLINE | ID: mdl-38718246

ABSTRACT

INTRODUCTION: In presenting this case of tick-borne illness in a patient with known disseminated blastomycosis, we aim to discuss the clinical reasoning and decision-making process when treating a septic presentation in a complex patient with multiple exposures and risk factors, from identifying and addressing the most devastating differentials to selecting appropriate empiric anti-infective regimens. CASE PRESENTATION: We present the case of a 60-year-old male with a medical history of diastolic heart failure, cirrhosis, sarcoidosis, hypertension, splenectomy, and recently diagnosed disseminated blastomycosis, who developed sepsis following a recent tick exposure. DISCUSSION: While a review of the literature revealed a paucity of cases of coexisting fungal and tick-borne illness, each is independently well-studied. Several reported commonalities exist between Blastomyces and Anaplasma, including endemic regions and at-risk populations.


Subject(s)
Anaplasmosis , Blastomycosis , Humans , Male , Blastomycosis/diagnosis , Blastomycosis/complications , Blastomycosis/drug therapy , Middle Aged , Anaplasmosis/diagnosis , Anaplasmosis/complications , Anaplasmosis/drug therapy , Diagnosis, Differential , Animals
7.
J Infect Chemother ; 30(12): 1309-1314, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38574814

ABSTRACT

Human granulocytic anaplasmosis (HGA) is a tick-borne infection caused by Anaplasma phagocytophilum. Only seven cases of HGA have been reported in Japan to date. We report the case of a 61-year-old female farmer who developed HGA with rash and rhabdomyolysis. The patient had fever and erythema covering the entire body, including the palms. An induration with an eschar was observed on the right leg, indicating that the patient had been bitten by a tick. Elevated serum creatinine and creatinine kinase levels and hematuria indicated rhabdomyolysis. We suspected Japanese spotted fever, a tick-borne illness caused by Rickettsia Japonica, and administered minocycline and ciprofloxacin for a week. Transient neutropenia and thrombocytopenia were observed, but the symptoms improved. Polymerase chain reaction (PCR) and antibody tests for R. japonica and Orientia tsutsugamushi, which causes scrub typhus, were both negative. The PCR test for severe fever with thrombocytopenia syndrome virus was also negative. Antibodies against A. phagocytophilum-related proteins were detected by western blotting, indicating seroconversion of IgG with paired serum samples, and the patient was diagnosed with HGA. HGA should be suspected in acute febrile patients with a history of outdoor activity and cytopenia, with or without a rash. A testing system and the accumulation of cases in Japan are necessary for the early diagnosis and appropriate treatment of HGA.


Subject(s)
Anaplasma phagocytophilum , Anaplasmosis , Anti-Bacterial Agents , Exanthema , Rhabdomyolysis , Humans , Female , Middle Aged , Rhabdomyolysis/diagnosis , Rhabdomyolysis/microbiology , Exanthema/microbiology , Exanthema/etiology , Exanthema/diagnosis , Anaplasma phagocytophilum/immunology , Anaplasma phagocytophilum/isolation & purification , Anaplasmosis/diagnosis , Anaplasmosis/complications , Anaplasmosis/drug therapy , Anaplasmosis/microbiology , Anti-Bacterial Agents/therapeutic use , Japan , Ciprofloxacin/therapeutic use , Minocycline/therapeutic use
8.
Sci Rep ; 14(1): 7820, 2024 04 03.
Article in English | MEDLINE | ID: mdl-38570576

ABSTRACT

Anaplasma marginale infection is one of the most common tick-borne diseases, causing a substantial loss in the beef and dairy production industries. Once infected, the pathogen remains in the cattle for life, allowing the parasites to spread to healthy animals. Since clinical manifestations of anaplasmosis occur late in the disease, a sensitive, accurate, and affordable pathogen identification is crucial in preventing and controlling the infection. To this end, we developed an RPA-CRISPR/Cas12a assay specific to A. marginale infection in bovines targeting the msp4 gene. Our assay is performed at one moderately high temperature, producing fluorescent signals or positive readout of a lateral flow dipstick, which is as sensitive as conventional PCR-based DNA amplification. This RPA-CRISPR/Cas12a assay can detect as few as 4 copies/µl of Anaplasma using msp4 marker without cross-reactivity to other common bovine pathogens. Lyophilized components of the assay can be stored at room temperature for an extended period, indicating its potential for field diagnosis and low-resource settings of anaplasmosis in bovines.


Subject(s)
Anaplasma marginale , Anaplasmosis , Cattle Diseases , Tick-Borne Diseases , Cattle , Animals , Anaplasma marginale/genetics , Anaplasmosis/diagnosis , Anaplasmosis/genetics , CRISPR-Cas Systems , Cattle Diseases/genetics , Tick-Borne Diseases/genetics
9.
Vet Res Commun ; 48(3): 1727-1740, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38536514

ABSTRACT

Anaplasma phagocytophilum, Anaplasma platys and Ehrlichia canis, responsible of diseases in dogs, are tick-borne pathogens with a proven or potential zoonotic role that have shown increasing prevalence worldwide. The aims of this retrospective study were to assess the frequency of Anaplasma spp. and Ehrlichia spp. exposure in dogs tested in a veterinary teaching hospital in Italy over a 9-year period, to compare the performance of the diagnostic tests used, to evaluate correlations with clinical data, and to genetically analyse the identified bacteria. During the study period, 1322 dogs tested by at least one of the rapid immunoenzymatic test, indirect immunofluorescent antibody test or end-point PCR assay for Anaplasmataceae detection were included. Dogs were tested if they had clinical signs or clinicopathological alteration or risk factors related to infection, and if they were potential blood-donor animals. Ninety-four of 1322 (7.1%) dogs tested positive for at least one pathogen: 53 (4.3%) for A. phagocytophilum, one (0.1%) for A. platys and 63 (4.6%) for E. canis. The number of dogs tested increased and the positivity rate progressively declined over the years. Comparison of tests showed a near-perfect agreement between serological tests and a poor agreement between PCR and indirect assays. A breed predisposition has been highlighted for A. phagocytophilum infection in hunting breed dogs and for E. canis infection in mixed breed dogs. Phylogeny confirmed potential zoonotic implications for A. phagocytophilum and showed no correlation of the identified bacteria with the geographical origin. Our study provides new insights into possible risk factors in dogs and evidenced discordant results between different tests, suggesting that a combination of serological and molecular assays is preferable for a correct diagnosis.


Subject(s)
Anaplasma , Anaplasmosis , Dog Diseases , Ehrlichiosis , Hospitals, Animal , Animals , Dogs , Italy/epidemiology , Retrospective Studies , Dog Diseases/microbiology , Dog Diseases/epidemiology , Dog Diseases/diagnosis , Anaplasma/isolation & purification , Anaplasma/genetics , Anaplasmosis/epidemiology , Anaplasmosis/microbiology , Anaplasmosis/diagnosis , Ehrlichiosis/veterinary , Ehrlichiosis/epidemiology , Ehrlichiosis/diagnosis , Ehrlichiosis/microbiology , Male , Female , Ehrlichia/isolation & purification , Ehrlichia/genetics , Ehrlichia canis/genetics , Ehrlichia canis/isolation & purification , Hospitals, Teaching , Prevalence
10.
J Clin Microbiol ; 62(3): e0104823, 2024 03 13.
Article in English | MEDLINE | ID: mdl-38329335

ABSTRACT

Human granulocytic anaplasmosis (HGA) is an emerging, rickettsial tick-borne disease caused by Anaplasma phagocytophilum. Sero-epidemiological data demonstrate that this pathogen has a worldwide distribution. The diagnosis of HGA requires a high index of clinical suspicion, even in endemic areas. In recent years, HGA has increasingly been reported from Asia and described in China, Japan, and Korea. We serologically and molecularly screened 467 patients with clinical suspicion of Anaplasmosis. The present study describes the epidemiology, clinical, and laboratory details of 6 confirmed and 43 probable cases of human granulocytic anaplasmosis. One of the HGA patients developed secondary invasive opportunistic Aspergillus fumigatus and Acinetobacter baumanii infection during the illness, which resulted in a fatal infection. The HGA patients without severe complications had excellent treatment responses to doxycycline. The emergence of this newly recognized tick-borne zoonotic HGA in North India is a significant concern for public health and is likely underdiagnosed, underreported, and untreated. Hence, it is also essential to establish a well-coordinated system for actively conducting tick surveillance, especially in the forested areas of the country.IMPORTANCEThe results of the present study show the clinical and laboratory evidence of autochthonous cases of Anaplasma phagocytophilum in North India. The results suggest the possibility of underdiagnosis of HGA in this geographical area. One of the HGA patients developed secondary invasive opportunistic Aspergillus fumigatus and Acinetobacter baumanii infection during the illness, which resulted in a fatal infection.


Subject(s)
Anaplasma phagocytophilum , Anaplasmosis , Tick-Borne Diseases , Animals , Humans , Anaplasmosis/diagnosis , Anaplasmosis/drug therapy , Anaplasmosis/epidemiology , Doxycycline/therapeutic use , China/epidemiology , India
11.
Article in English | MEDLINE | ID: mdl-38412957

ABSTRACT

Anaplasmosis is a vector-borne disease caused by Anaplasma (A.) spp. which currently is still rarely diagnosed in cats. This article describes 3 independent cases of anaplasmosis in cats from different regions of Germany presented to veterinarians in 2021. All cats showed unspecific clinical signs, such as fever, reduced general condition, and decreased appetite. One cat additionally had generalized limb pain, another showed reluctance to move as well as vomiting. On complete blood cell count, only 1 of 3 cats showed mild thrombocytopenia. A. phagocytophilum was detected in blood samples of all 3 cats by polymerase chain reaction. Additionally, in 2 cats (in which blood smears were evaluated) morulae could be detected within neutrophilic granulocytes. Initially, all 3 cats had highly elevated serum amyloid A (SAA) concentrations. Treatment with doxycycline caused a rapid improvement of clinical signs, followed by a decrease of SAA concentrations to normal levels as well as negative PCR results after a treatment duration of at least 28 days. In cats with fever, otherwise unspecific clinical signs with only mild or no hematological changes, elevated SAA concentrations, and previous exposure to ticks, attending veterinarians should consider anaplasmosis as differential diagnosis.


Subject(s)
Anaplasma phagocytophilum , Anaplasmosis , Cat Diseases , Ehrlichiosis , Animals , Cats , Anaplasmosis/diagnosis , Anaplasmosis/drug therapy , Doxycycline/therapeutic use , Extremities , Germany , Ehrlichiosis/complications , Ehrlichiosis/diagnosis , Ehrlichiosis/drug therapy , Ehrlichiosis/veterinary , Cat Diseases/diagnosis , Cat Diseases/drug therapy
12.
J Vet Intern Med ; 38(1): 440-448, 2024.
Article in English | MEDLINE | ID: mdl-38038253

ABSTRACT

BACKGROUND: Comprehensive descriptions of equids with granulocytic anaplasmosis (EGA) with neurologic or muscle disease and other atypical presentations are scarce in the literature. OBJECTIVE: Describe the clinical signs, laboratory findings, treatment, and outcome of equids with EGA with emphasis on neurologic and muscle disease. ANIMALS: Thirty-eight horses, 1 donkey. METHODS: Retrospective study. Equids with EGA were included. The electronic data base was searched from January 2000 to December 2022 using the words anaplasmosis, ehrlichiosis, granulocytic, and rickettsia. Signalment and clinical data were reviewed. Data were evaluated for normality using Shapiro-Wilk test. Parametric and nonparametric statistics were used for normally and non-normally distributed data. RESULTS: Common (41%) and other (59%) presentations were seen in horses ≥ 4 years of age (median, 14 years) with an overrepresentation of males (77%). Neurologic disease was common (41%), mainly presenting as diffuse symmetrical proprioceptive ataxia. Brain disease was less common manifesting as obtundation and cranial nerve deficits. Muscle disease was less common, with QH breeds with the variant causing myosin heavy chain myopathy (MYHM) having severe disease. Cavitary effusion, cardiomyopathy and disseminated intravascular coagulation (DIC) were uncommon. Clinical laboratory results varied depending on disease stage. Muscle enzyme activities were significantly higher in horses with muscle disease. Outcome was favorable with prompt tetracycline treatment. Death and long-term sequelae were not reported. CONCLUSIONS AND CLINICAL IMPORTANCE: Common and atypical presentations of EGA have a favorable outcome with prompt tetracycline treatment. Quarter horse breeds with muscle disease should be genotyped for MYHM.


Subject(s)
Anaplasma phagocytophilum , Anaplasmosis , Ehrlichiosis , Horse Diseases , Muscular Diseases , Male , Horses , Animals , Anaplasmosis/diagnosis , Anaplasmosis/drug therapy , Retrospective Studies , Anti-Bacterial Agents/therapeutic use , Equidae , Tetracycline/therapeutic use , Ehrlichiosis/diagnosis , Ehrlichiosis/drug therapy , Ehrlichiosis/veterinary , Muscular Diseases/veterinary , Muscles
13.
JAMA Neurol ; 81(2): 188-189, 2024 Feb 01.
Article in English | MEDLINE | ID: mdl-38147320

ABSTRACT

This case report describes a 51-year-old female with presented to the emergency department with high-grade fever, headache, nausea, vomiting, dizziness, diffuse arthralgias, and new-onset worsened vision that had developed over 3 days.


Subject(s)
Anaplasmosis , Animals , Humans , Anaplasmosis/complications , Anaplasmosis/diagnosis , Retinal Hemorrhage/etiology , Retinal Hemorrhage/complications
14.
BMJ Case Rep ; 16(11)2023 Nov 30.
Article in English | MEDLINE | ID: mdl-38035680

ABSTRACT

Due to climate change, infections from tickborne pathogens are becoming more prevalent in the Northern Hemisphere. Human granulocytic anaplasmosis, caused by the obligate intracellular gram-negative bacteria Anaplasma phagocytophilum and carried by Ixodes ticks, can lead to morbidity and mortality in select populations. Anaplasmosis is commonly accompanied by significant cytopaenia, the pathophysiology of which remains unknown. Our case report describes an uncommon meningoencephalitic presentation of anaplasmosis with substantial anaemia and thrombocytopaenia. Additionally, we propose a mechanism of bone marrow infection and suppression by A. phagocytophilum which may be responsible for the cytopaenia in anaplasmosis and provide pictographic evidence of anaplasma in peripheral blood, cerebrospinal fluid and bone marrow.


Subject(s)
Anaplasma phagocytophilum , Anaplasmosis , Encephalitis , Ixodes , Animals , Humans , Anaplasmosis/complications , Anaplasmosis/diagnosis , Anaplasmosis/drug therapy , Bone Marrow
16.
J Vector Borne Dis ; 60(3): 265-278, 2023.
Article in English | MEDLINE | ID: mdl-37843237

ABSTRACT

BACKGROUND & OBJECTIVES: Anaplasma phagocytophilum causes human granulocytic anaplasmosis; a febrile tick-borne bacterial zoonosis of increasing public health importance in many parts of the world which is life threatening in undiagnosed, misdiagnosed and untreated cases. In this study we determined and reported the global status of the pathogen in man. METHODS: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was used to perform a systematic review and meta-analysis of data published in six electronic databases between 1970 and 2020. We pooled data using the random-effects model, performed sensitivity analysis by the single study deletion method and assess across study bias by the funnel plot and its statistical significance by the Egger's regression test. RESULTS: A total of 7018 cases of A. phagocytophilum were reported from 48,619 individuals examined across 22 countries in three continents. Overall pooled estimate was 8.13% (95% CI: 5.70 - 11.47) with a range of 4.64 (95% CI: 1.78 - 11.54) to 12.18% (95% CI: 7.66 - 18.83) across sub-groups. Regional prevalence was highest in North America 11.07% (95% CI: 3.13 - 32.38), while that in relation to study population was highest among occupationally exposed population 11.41% (95% CI: 5.69 - 21.56). INTERPRETATION & CONCLUSION: The study revealed a significant variation in the prevalence of A. phagocytophilum across Asia, Europe and North America, with the highest prevalence in North America and among occupationally exposed population. To curtail the menace of this growing public health crisis, we recommend integrated control programmes involving tick control, the use of appropriate clothing by occupationally exposed population and health education.


Subject(s)
Anaplasmosis , Ticks , Animals , Humans , Anaplasmosis/diagnosis , Anaplasmosis/epidemiology , Anaplasmosis/microbiology , Ticks/microbiology
17.
Emerg Infect Dis ; 29(9): 1904-1907, 2023 09.
Article in English | MEDLINE | ID: mdl-37610264

ABSTRACT

We detected the DNA of an Anaplasma bovis-like bacterium in blood specimens from 4 patients from the United States with suspected tickborne illnesses. Initial molecular characterization of this novel agent reveals identity to A. bovis-like bacteria detected in Dermacentor variabilis ticks collected from multiple US states.


Subject(s)
Anaplasma , Anaplasmosis , Humans , Anaplasma/genetics , United States/epidemiology , Dermacentor/microbiology , Anaplasmosis/diagnosis
18.
Vector Borne Zoonotic Dis ; 23(10): 507-513, 2023 10.
Article in English | MEDLINE | ID: mdl-37603305

ABSTRACT

Background: Human granulocytic anaplasmosis (HGA) is a vector-borne natural focal disease that is not officially registered in Ukraine. The first 13 cases of HGA in adults in Ukraine were identified in 2007. The purpose of our study was to develop a predictive model of HGA based on clinical and laboratory characteristics to develop a three-level standard case definition of HGA. Materials and Methods: Researchers examined 498 patients with suspected tick-borne infections and carried out a retrospective clinical and epidemiological analysis of 60 cases recruited from Lviv regional infectious disease hospitals. Logistic regression was used to create a model of the probability of the diagnosis of HGA depending on the presence of certain clinical and laboratory factors that, when examined, together may help to confirm a case of HGA. For logistic regression, eight clinical and laboratory factors were selected: history of tick bite, hyperthermia, signs of pharyngitis, changes in chest X-ray picture (enhancement of the pulmonary pattern and enlargement of the lung root boundaries), increased bilirubin (˃21 µmol/L), increased alanine aminotransferase (ALT ˃36 U/L), erythema migrans, and detected Lyme disease. Results: In the presence of all eight factors, the probability of HGA is 95.7%. When the five main signs are absent-signs of pharyngitis, changes in chest X-ray picture, increased bilirubin and ALT, and a history of tick bite-the probability of HGA in the patient dramatically decreases to 6.8%, meaning that HGA might be excluded. Conclusions: Based on the analysis of epidemiological, clinical, and laboratory signs, criteria for establishing a suspected, probable, and confirmed diagnosis of HGA have been developed to improve diagnosis.


Subject(s)
Anaplasmosis , Pharyngitis , Tick Bites , Adult , Animals , Humans , Anaplasmosis/diagnosis , Tick Bites/veterinary , Retrospective Studies , Pharyngitis/veterinary , Bilirubin
19.
PLoS One ; 18(6): e0286631, 2023.
Article in English | MEDLINE | ID: mdl-37267407

ABSTRACT

Due to environmental and ecological changes and suitable habitats, the occurrence of vector-borne diseases is increasing. We investigated the seroprevalence of four major vector-borne pathogens in human patients with febrile illness who were clinically suspected of having Scrub Typhus (ST) caused by Orientia tsutsugamushi. A total of 187 samples (182 patient whole blood and sera samples, including 5 follow-up) were collected. Antibodies to Anaplasma phagocytophilum, Ehrlichia chaffeensis, Borrelia burgdorferi, and Bartonella henselae were tested by using indirect immunofluorescence assays. Molecular diagnoses were performed using real-time PCR. Of the 182 cases, 37 (20.3%) cases were designated as confirmed cases of ST, and the remaining 145 (79.7%) cases as other febrile diseases (OFDs). The seroprevalence of A. phagocytophilum, E. chaffeensis, B. burgdorferi, and B. henselae was 51.4% (19/37), 10.8% (4/37), 86.5% (32/37), and 10.8% (4/37) among the ST group, and 42.8% (62/145), 10.4% (19/145), 57.7% (105/145), and 15.9% (29/145) among the OFD group, respectively. There were no significant differences in the seroprevalence between the ST and the OFD groups. Considering the co-occurrence, 89.0% (162/182) had at least one antibody to tick-borne pathogens, 37.0% (60/162) were positive for two pathogens, 17.3% (28/162) for three pathogens, and 6.2% (10/162) for four pathogens. In real-time PCR, O. tsutsugamushi was positive in 16 cases [15 (40.5%) in ST group and 1 (2.2%) in OFD group], and the four other pathogens were negative in all cases except one confirmed as anaplasmosis. In evaluating the five follow-up samples, the appearance of new antibodies or an increase in the pre-existing antibody titers was detected. Our data highlighted that acute febrile illness and manifestations suggestive of a vector-borne infection must be recognized and further considered for coinfections in clinical practice and the laboratory.


Subject(s)
Anaplasma phagocytophilum , Anaplasmosis , Ehrlichiosis , Rickettsia , Scrub Typhus , Tick-Borne Diseases , Animals , Humans , Scrub Typhus/diagnosis , Scrub Typhus/epidemiology , Seroepidemiologic Studies , Anaplasmosis/diagnosis , Anaplasmosis/epidemiology , Anaplasma phagocytophilum/genetics , Ehrlichiosis/diagnosis , Ehrlichiosis/epidemiology , Tick-Borne Diseases/diagnosis , Tick-Borne Diseases/epidemiology
20.
Future Cardiol ; 19(4): 197-202, 2023 Mar.
Article in English | MEDLINE | ID: mdl-37313836

ABSTRACT

We present a case of a 54-year-old gentleman with a history of hypertension and chronic HIV who presented with fever and epigastric pain, found to have elevated troponin-I levels and diffuse ST-segement elevations on ECG without clinical evidence of ischemia concerning for myopericarditis. Initial laboratory findings also included thrombocytopenia and elevated aminotransferases as well as computed tomography imaging revealing splenic infarcts. Given plausible exposure to ticks, this led to the eventual diagnosis of anaplasmosis confirmed on PCR assay. Cardiac MRI images confirmed myocardial involvement, which resolved with antibiotic treatment. While rare, cardiac involvement is possible sequelae of anaplasmosis infection as illustrated by this case.


Subject(s)
Anaplasmosis , Myocarditis , Pericarditis , Male , Animals , Humans , Middle Aged , Anaplasmosis/complications , Anaplasmosis/diagnosis , Pericarditis/diagnosis , Pericarditis/etiology , Pericarditis/therapy , Myocarditis/diagnosis , Myocarditis/etiology , Myocarditis/therapy , Troponin I
SELECTION OF CITATIONS
SEARCH DETAIL